Cramer Weighs In On Blackstone, Oramed Pharmaceuticals And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said FMC Corp (NYSE: FMC) had a cost problem and Fermium Research downgraded it.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows.
Citigroup Maintains Neutral on FMC, Lowers Price Target to $109
Citigroup analyst PJ Juvekar maintains FMC (NYSE:FMC) with a Neutral and lowers the price target from $118 to $109.
Keybanc Maintains Overweight on FMC, Lowers Price Target to $122
Keybanc analyst Aleksey Yefremov maintains FMC (NYSE:FMC) with a Overweight and lowers the price target from $136 to $122.
Recap: FMC Q2 Earnings
Shares of FMC (NYSE:FMC) fell in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 5.23% over the past year to $1.81, which beat the estimate of $1.78.
FMC Q2 EPS $1.81 Beats $1.78 Estimate, Sales $1.24B Beat $1.23B Estimate
FMC (NYSE:FMC) reported quarterly earnings of $1.81 per share which beat the analyst consensus estimate of $1.78 by 1.69 percent. This is a 5.23 percent increase over earnings of $1.72 per share from the same period last
Earnings Scheduled For August 3, 2021
Companies Reporting Before The Bell
• Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter.
• Stellantis (NYSE:STLA) is expected to report earnings for its second quarter.
Loop Capital Downgrades FMC to Hold, Lowers Price Target to $122
Loop Capital analyst Christopher Kapsch downgrades FMC (NYSE:FMC) from Buy to Hold and lowers the price target from $128 to $122.